Nordson Corporation (NDSN) reported solid fourth-quarter results, with total sales reaching $752 million, a 1% increase year-over-year, despite a 1% decline in organic sales. Adjusted earnings per share (EPS) rose 9% to $3.03, surpassing guidance, while the EBITDA margin improved to 34%, marking the third consecutive quarter of expansion. The company generated a record quarterly EBITDA of $256 million and a free cash flow of $194 million, allowing for significant shareholder returns, including $300 million in share repurchases.
These results reflect Nordson’s successful execution of its “Ascend Strategy,” which emphasizes operational efficiency and strategic portfolio optimization. The medical segment showed strong growth, with sales up 10%, while industrial precision solutions faced a slight decline. The company anticipates mid-single-digit sales growth and high-single-digit EPS growth for 2026, driven by a stable backlog of approximately $600 million.
For market professionals, Nordson’s strong cash flow and commitment to shareholder returns highlight its resilience amid macroeconomic challenges, making it a potentially attractive investment as it navigates a dynamic landscape.
Source: fool.com